nach oben

Neurological Sciences

Erschienen in:

01.06.2012 | Original Article

Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats

verfasst von: Ertugrul Uzar, Harun Alp, Mehmet Ugur Cevik, Ugur Fırat, Osman Evliyaoglu, Adnan Tufek, Yasar Altun

Erschienen in: Neurological Sciences | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate the possible effects of ellagic acid in brain and sciatic nerve tissues of diabetic rats. Also, the impact of ellagic acid on catalase and paraoxonase (PON-1) activities, total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), malondialdehyde (MDA) and nitric oxide (NO) were examined. The rats were randomly divided into four groups, with eight rats each: Normal controls (not diabetic), only ellagic acid treated (ellagic acid controls, not diabetic), Diabetic controls (streptozotocin, diabetic), ellagic acid-treated diabetic (streptozotocin + ellagic acid). After a 4 week experiment, rats were sacrificed, and biomarkers for oxidative stress in the brain and sciatic nerve tissues of the rats were measured. There was significant depletion in the PON-1, catalase, and TAS levels in the brain and sciatic nerve tissues compared to the control groups (for both parameters, p < 0.05). The values of catalase, PON-1 and TAS reversed back to normal levels in ellagic acid-treated diabetic rats compared to untreated diabetic rats (for both parameters, p < 0.05). The levels of MDA, TOS, NO and, OSI in the brain and sciatic nerve tissues were higher in untreated diabetic rats compared to control group (for both parameters p < 0.05). However, MDA, TOS, OSI, and NO levels were found to be significantly reduced in the ellagic acid-treated diabetic group compared to the untreated diabetic group in these tissues (for both parameters, p < 0.05). In conclusion, the results of the present study suggested that ellagic acid exhibits neuroprotective effects against oxidative damage in diabetic rats.

Manschot SM, Biessels GJ, Rutten GE, Kessels RP, Gispen WH, Kappelle LJ, Utrecht Diabetic Encephalopathy Study Group (2008) Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients. J Neurol Sci 264:157–162PubMedCrossRef

Ozkul A, Ayhan M, Yenisey C, Akyol A, Guney E, Ergin FA (2010) The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain. Neuro Endocrinol Lett 31:261–264PubMed

Osawa T, Kato Y (2005) Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann N Y Acad Sci 1043:440–451PubMedCrossRef

Gumieniczek A (2005) Effects of pioglitazone on hyperglycemia-induced alterations in antioxidative system in tissues of alloxan-treated diabetic animals. Exp Toxicol Pathol 56:321–326PubMedCrossRef

Chandrasekharan B, Anitha M, Blatt R, Shahnavaz N, Kooby D, Staley C, Mwangi S, Jones DP, Sitaraman SV, Srinivasan S (2011) Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterol Motil 23:131–138PubMedCrossRef

Okouchi M, Okayama N, Aw TY (2009) Preservation of cellular glutathione status and mitochondrial membrane potential by N-acetylcysteine and insulin sensitizers prevent carbonyl stress-induced human brain endothelial cell apoptosis. Curr Neurovasc Res 6:267–278PubMedCrossRef

Bakkalbasi E, Mentes O, Artik N (2009) Food ellagitannins-occurrence, effects of processing and storage. Crit Rev Food Sci Nutr 49:283–298PubMedCrossRef

Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16:360–367PubMedCrossRef

Ou HC, Lee WJ, Lee SD, Huang CY, Chiu TH, Tsai KL, Hsu WC, Sheu WH (2010) Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3 K/Akt/eNOS pathway. Toxicol Appl Pharmacol 248:134–143PubMedCrossRef

10.

Ueda H, Kawanishi K, Moriyasu M (2004) Effects of ellagic acid and 2-(2, 3, 6-trihydroxy-4-carboxyphenyl) ellagic acid on sorbitol accumulation in vitro and in vivo. Biol Pharm Bull 27:1584–1587PubMedCrossRef

11.

Shanmugam KR, Mallikarjuna K, Kesireddy N, Sathyavelu Reddy K (2011) Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food Chem Toxicol 49:893–897PubMedCrossRef

12.

Alp H, Aytekin I, Atakisi O, Hatipoglu NK, Basarali K, Ogun M, Buyukbas S, Altintas L, Ekici H, Alp A (2011) The effects of caffeic acid phenethyl ester and ellagic acid on the levels of malondialdehyde, reduced glutathione and nitric oxide in the lung, liver and kidney tissues in acute diazinon toxicity in rats. J Anim Vet Adv 10:1488–1494CrossRef

13.

Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the Folin phenol reagent. J Biochem Chem 19:265–275

14.

Ohkawa H, Ohishi N, Tagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMedCrossRef

15.

Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440–1443PubMed

16.

Eckerson HW, Wyte CM, La Du BN (1983) The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 35:1126–1138PubMed

17.

Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126PubMedCrossRef

18.

Erel O (2004) A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 37:112–119PubMedCrossRef

19.

Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38:1103–1111PubMedCrossRef

20.

Ozturk E, Balat O, Acılmıs YG, Ozcan C, Pence S, Erel O (2011) Measurement of the placental total antioxidant status in preeclamptic women using a novel automated method. J Obstet Gynaecol Res 37:337–342PubMedCrossRef

21.

Aslan M, Sabuncu T, Kocyigit A, Celik H, Selek S (2007) Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 17:734–740PubMedCrossRef

22.

Yilmaz HR, Uz E, Yucel N, Altuntas I, Ozcelik N (2004) Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol 18:234–238PubMedCrossRef

23.

Kumar A, Kaundal RK, Iyer S, Sharm SS (2007) Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci 80:1236–1244PubMedCrossRef

24.

Umesalma S, Sudhandiran G (2010) Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin Pharmacol Toxicol 107:650–655PubMedCrossRef

25.

Maes M, Galecki P, Chang YS, Berk M (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiat 35:676–692CrossRef

26.

Chao PC, Hsu CC, Yin MC (2009) Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice. Nutr Metab (Lond). doi:10.1186/1743-7075-6-33

27.

Chao CY, Mong MC, Chan KC, Yin MC (2010) Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res 54:388–395PubMedCrossRef

28.

Kawanishi K, Ueda H, Moriyasu M (2003) Aldose reductase inhibitors from the nature. Curr Med Chem 10:1353–1374PubMedCrossRef

29.

Nambu H, Kubo E, Takamura Y, Tsuzuki S, Tamura M, Akagi Y (2008) Attenuation of aldose reductase gene suppresses high-glucose-induced apoptosis and oxidative stress in rat lens epithelial cells. Diabetes Res Clin Pract 82:18–24PubMedCrossRef

30.

Inoue M, Suehiro T, Nakamura T, Ikeda Y, Kumon Y, Hashimoto K (2000) Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes. Metabolism 49:1400–1405PubMedCrossRef

31.

Stefanovic A, Kotur-Stevuljevic J, Spasic S et al (2010) HDL 2 particles are associated with hyperglycaemia, lower PON1 activity and oxidative stress in type 2 diabetes mellitus patients. Clin Biochem 43:1230–1235PubMedCrossRef

32.

Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ (2008) Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model. Life Sci 82:301–307PubMedCrossRef

33.

Rosenblat M, Hayek T, Aviram M (2006) Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. Atherosclerosis 187:363–371PubMedCrossRef

34.

Kabay SC, Ozden H, Guven G et al (2009) Protective effects of vitamin E on central nervous system in streptozotocin-induced diabetic rats. Clin Invest Med 32:314–321

Titel: Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats
verfasst von: Ertugrul Uzar
Harun Alp
Mehmet Ugur Cevik
Ugur Fırat
Osman Evliyaoglu
Adnan Tufek
Yasar Altun
Publikationsdatum: 01.06.2012
Verlag: Springer Milan
Erschienen in: Neurological Sciences / Ausgabe 3/2012
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-011-0775-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Hemiparesthesias in lacunar pontine ischemic stroke

Ginevra de Benci’s portrait: had the lady a myopathic face?

Cerebral venous and sinus thrombosis associated with subcutaneous immunoglobulin injection and oral contraceptive use

Neurodegeneration in the course of Langerhans cell histiocytosis

The roles of P2X7 receptor in regional-specific microglial responses in the rat brain following status epilepticus